← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2011Last known activity
Jan 31, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (17 distinct, 9 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07232706Lead sponsorPhase 3Jan 31, 2026
- NCT05117398Lead sponsorPhase 3Jan 3, 2022
- NCT05154383Lead sponsorPhase 4Nov 15, 2021
- NCT05154383Overall official - principal investigatorPhase 4Nov 15, 2021
- NCT04900467Overall official - principal investigatorN/AMay 28, 2021
- NCT04547504Overall official - principal investigatorPhase 3Dec 22, 2020
- NCT03892148CollaboratorPhase 4May 10, 2019
- NCT03669523Overall official - principal investigatorPhase 2Oct 31, 2018
- NCT01963442Overall official - principal investigatorPhase 2Nov 1, 2013
- NCT01152346Overall official - principal investigatorPhase 1Apr 1, 2011
Details
- Founded
- Épagny-Metz-Tessy, FR
- Last known activity
- Jan 31, 2026